Main description:

Hepatocellular Carcinoma: Targeted Therapy provides a detailed repository of the latest information regarding HCC epidemiology, diagnosis, imaging, pathology, staging, and treatment options. This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including, surgical resection, liver transplantation, ablation (radiofrequency, microwave), percutaneous ethanol or acetic acid injection, transarterial chemoembolization (TACE), intra-arterial radiation therapy, and systemic chemotherapy. Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and treatment of HCC, including surgeons, medical oncologists, radiologists, radiation oncologists, and pathologists.

Contents:

Epidemiology and Pathogenesis of HCC (TBA)

HCC in patients without cirrhosis or hepatitis (Dr. Robert Martin, University of Louisville) (UNIQUE TO THIS TEXT)

Pathology considerations (TBA)

Diagnosis of HCC: the role of imaging studies

Screening Programs in High-Risk Populations

Treatment Overview: Assembling a multidisciplinary team and selection of appropriate treatment options (Drs. McMasters and Dr. Vauthey)

Evidence-based guidelines for treatment of HCC in Japan (Dr. Norihiro Kokudo, University of Tokyo)

Liver Resection for HCC (Drs. Vauthey and Eddie Abdalla, MD Anderson Cancer Center)

Portal Vein Embolization prior to resection (Dr. Norihiro Kokudo) (UNIQUE TO THIS TEXT)

Laparoscopic Liver Resection for HCC (Dr. Joseph Buell, University of Louisville) (UNIQUE TO THIS TEXT)

Liver Transplantation for HCC

Resection and reconstruction of inferior vena cava and hepatic veins for advanced HCC (Dr. Alan Hemming, University of Florida)

Radiofrequency ablation for HCC (Dr. Ronnie Poon, University of Hong Kong)

Microwave ablation (Drs. McMasters and Robert Martin, University of Louisville)

Transarterial Chemoembolization (TBA)

Intra-arterial chemotherapy bead therapy (UNIQUE TO THIS TEXT) (Dr. Robert Martin, University of Louisville)

Radioactive microsphere therapy (TBA) (UNIQUE TO THIS TEXT)

Targeted Therapies for HCC (Dr. Josep Llovet, Mount Sinai School of Medicine, NY) (UNIQUE TO THIS TEXT)

Systemic Therapy Options for HCC (TBA)

Patient follow-up strategies and salvage therapy for recurrence (UNIQUE TO THIS TEXT) Drs. McMasters and Vauthey